StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Bertz24on Jun 10, 2020 10:47am

72 Views

Post# 31133152

RE:Sorry we aren't selling. Nice try

Exactly.. States are under reporting and cases are spiking again in the USA.. Market may not be interested in Covid at the moment.. But it's still out there.

"With public and private labs now performing more than 400,000 tests most days – a figure the U.S. Department of Health and Human Services projects will more than double by late summer – some question whether accelerated testing comes at a cost. A strategy built on the quantity of tests does not account for nuances and limitations, lacks coordination and wastes limited testing supplies."
https://www.usatoday.com/story/news/health/2020/06/06/coronavirus-test-covid-19-tests-increase-plan-lacking/3138440001/

LithLover wrote: You can create as many new accounts and bash as much as you want. The company has laid out plans with the overnight funding in a 44 page prospectus. The offering is expected to close by June 18 and I'm sure shortly after that we will receive an update.

In the meantime we can see the need for more testing continues to grow.

We are holding to learn of the final closing details and to get an update. It's clear the MMs are keeping it in this range as well so that is also a good sign.

Posting constantly is just a waste of time and shows your lack of business acumen.

So give it a rest